User contributions

Jump to: navigation, search
Search for contributionsExpandCollapse
⧼-contribs-top⧽
⧼-contribs-date⧽

  • 19:09, 4 September 2024 diff hist +11,928 N Mcintyrebrix7700Created page with "progression free survival remains the most common endpoint in phase III trials.<br /><br /> The association of primary oncologist specialty, medical oncology versus gynecologi..." current